Navigation Links
Identification of cells in S phase using the Cell Proliferation Fluorescence Kit and IN Cell Analyzer 1000


The cell cycle is of key importance to many areas of drug discovery. On the one hand this fundamental process provides the opportunity to discover new therapeutic targets for anti-cancer agents, and on the other hand drugs and targets in other therapeutic areas must be tested for undesirable effects on the cell cycle.

The Cell Proliferation Fluorescence Kit is a precise, fast, and simple fluorescence assay to quantitate cell proliferation, study the regulation of DNA synthesis, or observe the degree of inhibition of cell progression through S phase. It is based on the measurement of 5-bromo-2'-deoxyuridine (BrdU) incorporation during DNA synthesis in proliferating cells.

BrdU (an analog of the DNA precursor thymidine) is incorporated into newly synthesized DNA by cells entering and progressing through the S (DNA synthesis) phase of the cell cycle. The incorporated BrdU is detected with a specific anti-BrdU monoclonal antibody, followed by a Cy™5 labeled antibody to mouse immunoglobulin, giving a fluorescent signal at sites of BrdU incorporation. This provides an excellent marker for identifying cells that are in S phase, and also for determining the proportion of cells in S phase of the cell cycle.

The intensity of nuclear-associated Cy5 fluorescence is measured using an IN Cell Analyzer 1000 and the data analyzed using an Object Intensity Analysis Module.

The use of a Cy5 red-shifted fluor enables this technology to be multiplexed with green fluorescent protein (GFP). This assay provides a high-throughput method for the identification and analysis of cells that have actively synthesized DNA.


Materials
Products used

IN Cell Analyzer 1000 25-8010-26

Object Intensity Analysis Module 25-8010-56
for IN Cell Analyzer 1
'"/>

Source:


Page: All 1 2 3 4 5

Related biology technology :

1. Identification of Differentially Expressed Gene Products with the CastAway System*
2. An Optimal DNA Microarray Substrate for the Identification of Fetal and Somatic Liver Stem Cells of the Rat
3. Identification of Low-Level Oxidation Products in Calmodulin Using NanoSpray Ion Trap Mass Spectrometry
4. Detection and Identification of Phosphorylation Sites in Proteins Using LC/MS/MS with Neutral Fragment Loss Mapping
5. Protect RNA and Improve Target Cell Identification
6. Identification of Disease Causing Mutations in Phenylketonuria by Denaturing Gradient Gel Electrophoresis Using the DCode System
7. Identification of Nonspecific Products Using Melt-Curve Analysis on the iCycler iQ Detection System, Rev A
8. Identification of Insecticides and Herbicides by LC/MS/MS Using the API 2000 LC/MS/MS System
9. Identification of Phase I and Phase II Metabolites of Buspirone on the Q TRAP LC/MS/MS System
10. ESR1 Gene Expression in Oncology and Metabolic Diseases Using the ASCENTATM System Target Validation and Identification of Novel Disease Indications
11. Easy preparation of total RNA from cultured cells with TRIzol and Eppendorf Phase Lock Gel

Post Your Comments:
(Date:11/23/2009)...Call/--CornerstoneTherapeuticsInc.(Nasdaq: CRTX ),...developingandcommercializingsignificantproductspri...uncedthatCraigA.Collard,PresidentandChiefExecutive...tAnnualPiperJaffrayHealthCareConferenceat3:30PMETo...NewYorkCity. ,, AliveaudioandarchivedwebcastofC...
(Date:11/20/2009)...FirstCall/ -- Dendreon Corporation (Nasdaq: DNDN ...nistration (FDA) provided written acknowledgement ...cation (BLA) for PROVENGE® (sipuleucel-T) is ...ription Drug User Fee Act (PDUFA) date of May 1, 2...mended BLA. Dendreon is seeking licensure for PRO...
(Date:11/20/2009)...recently announced that a free webinar, “Rol... Particle Characterization”, will be present...ication of in situ particle characterization is de...series of roller compaction runs while varying raw...es. , (PRWEB) November 20...
(Date:11/19/2009)...irstCall/ -- Omeros Corporation (Nasdaq: OMER ) t... third quarter ended September 30, 2009. For the t...ted a net loss of $3.9 million, or $1.34 per share....54 per share, for the same period in 2008. For th...y reported a net loss of $15.5 million, or $5.29 p...
Breaking Biology Technology:Cornerstone Therapeutics to Present at the 21st Annual Piper Jaffray Health Care Conference 2Dendreon Receives FDA Acknowledgement of Complete Response 2Dendreon Receives FDA Acknowledgement of Complete Response 3Roller Compaction Process Optimization Using At-Line Particle Characterization 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8
...Kind,Corporation (Nasdaq: MNKD ), focused on disc... for diabetes and cancer, announced today that it,...rence on September 25,2007 at 10:30 AM ET at the G...ies can access a link to the live web cast of the,...the Company,s website at, http://www.mannkindcorp....
... Biosciences,Incorporated (Nasdaq: KOSN ) announc...resident and Chief Financial Officer, will present...n New York at the Grand Hyatt on,Tuesday, Septembe...may access a live webcast of the presentation by,v...stors/Press" tab on,Kosan,s website at http://www...
...nical Studies Demonstrate Activity of Inv... CHICAGO, Sept. 18 Astellas Pharma US, Inc. and,...results with the,investigational compound telavanc...ated complicated skin and skin structure infection...ram in patients with,complicated Gram-positive cSS...
Other Biology Technology:Kosan Biosciences to Present at the 2007 UBS Global Life Sciences Conference 2Astellas and Theravance Report Additional Telavancin Data at 47th Annual ICAAC 2Astellas and Theravance Report Additional Telavancin Data at 47th Annual ICAAC 3Astellas and Theravance Report Additional Telavancin Data at 47th Annual ICAAC 4Astellas and Theravance Report Additional Telavancin Data at 47th Annual ICAAC 5Astellas and Theravance Report Additional Telavancin Data at 47th Annual ICAAC 6
(Date:11/22/2009)...s have succeeded in producing the polymers used fo... than through the use of fossil fuel based chemica...low for the production of environmentally consciou...nal Biotechnology and Bioengineering to mark the...ecules found in everyday life in the form of plast...
(Date:11/22/2009)...harmaceuticals today announced that its scientists...tated IDH1 gene has a novel enzyme activity consis... breakthrough discovery shows that the mutated for...e (2HG), which may contribute to the formation and... type of brain cancers. This discovery appears to ...
(Date:11/20/2009)...ber 2009 issue of the journal GENETICS ( http://...f genes (1-aminocyclopropane-1-carboxylate synthas... ethylene. This gas affects many aspects of plant ...ion for future genetic manipulation that could mak...rive in difficult terrain, increase yields, and ot...
Breaking Biology News(10 mins):Bioengineers succeed in producing plastic without the use of fossil fuels 2Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer 2Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer 3Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer 4It's a gas: New discovery may lead to heartier, high-yielding plants 2Slightly Underactive Thyroid May Be a Plus 48794 1Slightly Underactive Thyroid May Be a Plus 48794 2Slightly Underactive Thyroid May Be a Plus 48794 3WebMD to Present at Jefferies 3rd Annual Healthcare Conference 48792 1Xanodyne Announces Appointment of Mr Vaughn M Kailian of MPM Capital to the Board of Directors 48789 1Xanodyne Announces Appointment of Mr Vaughn M Kailian of MPM Capital to the Board of Directors 48789 2
... Two proteins interact in a previously unknown mol...in future studies looking for the causes of defect...r diseases, according to researchers at Cincinnati...their work in the Oct. 15 Genes & Development , t... identity and behavior in the forming organs of em...
...NG, Mich. Only six months after undergoing a uniq...sity, Jake part dog and now part machine spends ...raversing obstacle courses and prancing around pai...triever, was the first dog in the Midwest and only...w, cementless elbow prosthesis last April. The pro...
...an aid workers responding to devastating flooding ...ith satellite images of affected areas provided ra...arter on Space and Major Disasters. , Tens of tho...have been claimed by floods and landslides brought...American country on 16 October. , On 27 October, t...
Other Biology News:New regulatory mechanism discovered for cell identify and behavior in forming organs 2New regulatory mechanism discovered for cell identify and behavior in forming organs 3Innovative surgery by MSU veterinarian provides new lease on life to dogs 2Satellites helping aid workers in Honduras 2
Goat Anti-Mouse IGSF4 Polyclonal Antibody, Unconjugated from R&D Systems
Rat Anti-Mouse Activin RIB / ALK-4 Monoclonal Antibody, Unconjugated, Clone 207304 from R&D Systems
Normal Human Serum from 3H Biomedical AB
...eacon Designer designs oligos for SYBR Green, TaqM...n, NASBA and FRET assays. Highly specific primers ... automatically interpreting BLAST search results. ... secondary structures identified by connecting to ...
Biology Products: